Business · 25/09/1998Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 14 New Drug Applications and 13 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn approval of 14 new drug applications (NDAs) and 13 abbreviated new drug applications (ANDAs) following notifications from the applicants that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →